Respiratory Syncytial Virus –Associated Respiratory Diseases in Children and Adults

CONCLUSION: The approval of new RSV-specific monoclonal antibodies and active vaccinations enables targeted prevention of RSV infection in the main population groups at risk.PMID:38652840 | DOI:10.3238/arztebl.m2024.0060

Source: Deutsches Arzteblatt International - April 23, 2024 Category: General Medicine Authors: Tobias Tenenbaum Johannes Liese Tobias Welte Jessica Rademacher Source Type: research